Literature DB >> 3029867

The regulation of natural anticoagulant pathways.

C T Esmon.   

Abstract

Vascular endothelium plays an active role in preventing blood clot formation in vivo. One mechanism by which prevention is achieved involves a cell surface thrombin-binding protein, thrombomodulin, which converts thrombin into a protein C activator. Activated protein C then functions as an anticoagulant by inactivating two regulatory proteins of the coagulation system, factors Va and VIIIa. The physiological relevance of the protein C anticoagulant pathway is demonstrated by the identification of homozygous protein C--deficient infants with severe thrombotic complications. Recent studies suggest that this pathway provides a link between inflammation and coagulation.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3029867     DOI: 10.1126/science.3029867

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  106 in total

1.  Enhancing Thrombolysis with Adjunctive Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

2.  The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

Authors:  R L Nachman
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

3.  Coagulation pathways and diabetic retinopathy: abnormal modulation in a selected group of insulin dependent diabetic patients.

Authors:  C Giusti; R Schiaffini; C Brufani; A Pantaleo; E M Vingolo; P Gargiulo
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

4.  Activation and degradation of protein C by primary rabbit pleural mesothelial cells.

Authors:  Alexei Iakhiaev; Steven Idell
Journal:  Lung       Date:  2006 Mar-Apr       Impact factor: 2.584

5.  Production of recombinant protein C in serum-containing and serum-free perfusion culture.

Authors:  T Sugiura; H B Maruyama
Journal:  Cytotechnology       Date:  1991-11       Impact factor: 2.058

6.  Protein S gene mutation in a young woman with type III protein S deficiency and venous thrombosis during pregnancy.

Authors:  Masaya Hirose; Fuminori Kimura; Hua-Qin Wang; Koichi Takebayashi; Masashi Kobayashi; Keiko Nakanishi; Minoru Akiyama; Toshio Kimura; Yoichi Noda
Journal:  J Thromb Thrombolysis       Date:  2002-04       Impact factor: 2.300

7.  Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

Authors:  G P Gasic; C P Arenas; T B Gasic; G J Gasic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

8.  Transcription of thrombomodulin mRNA in mouse hemangioma cells is increased by cycloheximide and thrombin.

Authors:  W A Dittman; T Kumada; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

9.  Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors.

Authors:  D Kirchhofer; T B Tschopp; P Hadváry; H R Baumgartner
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

Review 10.  Endothelial-dependent procoagulant and anticoagulant mechanisms. Recent advances in understanding.

Authors:  C R Benedict; R Pakala; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.